Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW685698X dose-ranging study in persistent asthma
2005-001122-87Phase 2Terminated
- Sponsor
- GSK
- Start
- Jun 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluticasone propionate in persistent asthma (6 arms), sponsored by GSK. Primary endpoint: Mean change from baseline to end of 8-week treatment in trough FEV1. Started Jun 2005; status: terminated.
02
Drugs
fluticasone propionate
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2005-001122-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001122-87.